The present report describes extrapyramidal side effects (EPS) appearing after 32 months of exclusive treatment with clozapine at low dosages.This case evidences that long-term treatment with clozapine may be associated with EPS and suggests that, even if clozapine is considered the medication with the fewest EPS and it is often prescribed as an effective treatment for them, its use does not fully eliminate the risk of neurological side effects.
Clozapine-related extrapyramidal side effects: a case report / Gallo, Mariana; Squarcione, Chiara; Bersani, Francesco Saverio; Minichino, Amedeo; Fojanesi, Marta; Biondi, Massimo. - In: RIVISTA DI PSICHIATRIA. - ISSN 0035-6484. - 52:4(2017), pp. 172-173.
Clozapine-related extrapyramidal side effects: a case report
Gallo, Mariana;Bersani, Francesco Saverio;Minichino, Amedeo;Fojanesi, Marta;Biondi, Massimo
2017
Abstract
The present report describes extrapyramidal side effects (EPS) appearing after 32 months of exclusive treatment with clozapine at low dosages.This case evidences that long-term treatment with clozapine may be associated with EPS and suggests that, even if clozapine is considered the medication with the fewest EPS and it is often prescribed as an effective treatment for them, its use does not fully eliminate the risk of neurological side effects.| File | Dimensione | Formato | |
|---|---|---|---|
|
Gallo_Clozapine-related_2017.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
31.56 kB
Formato
Adobe PDF
|
31.56 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
